5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.73▼ | 2.77▼ | 2.77▼ | 2.63▲ | 2.51▲ |
MA10 | 2.76▼ | 2.78▼ | 2.80▼ | 2.45▲ | 2.34▲ |
MA20 | 2.77▼ | 2.82▼ | 2.79▼ | 2.56▲ | 1.95▲ |
MA50 | 2.83▼ | 2.74▼ | 2.57▲ | 2.30▲ | 4.83▼ |
MA100 | 2.81▼ | 2.53▲ | 2.50▲ | 1.97▲ | 7.33▼ |
MA200 | 2.64▲ | 2.53▲ | 2.66▲ | 4.19▼ | 11.47▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.006▼ | -0.018▼ | -0.026▼ | 0.015▲ | 0.303▲ |
RSI | 35.854▼ | 41.984▼ | 49.435▼ | 55.548▲ | 47.233▼ |
STOCH | 4.550▼ | 40.540 | 25.788 | 61.299 | 60.044 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -41.593 | -32.489 |
CCI | -123.647▼ | -159.444▼ | -124.455▼ | 81.104 | 69.602 |
CDL | $ANVS Marubozu Candlestick Pattern Detected | Set Alert |
Thursday, June 26, 2025 05:02 AM
Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such ...
|
Monday, June 23, 2025 12:25 AM
Annovis Bio Inc. (NYSE:ANVS) is part of the biotechnology sector, a space known for its intensive research and development phase prior to generating revenue. The company is listed on both the NYSE ...
|
Sunday, June 22, 2025 12:29 AM
NYSE:ANVS Debt to Equity History June 22nd 2025. See our latest analysis for Annovis Bio . How Is Annovis Bio's Cash Burn Changing Over Time? Because Annovis Bio isn't currently generating revenue ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
11/07/25 | 2.85 | 2.85 | 2.70 | 2.71 | 330,200 |
10/07/25 | 2.73 | 2.97 | 2.72 | 2.85 | 366,000 |
09/07/25 | 2.59 | 2.78 | 2.57 | 2.72 | 337,400 |
08/07/25 | 2.40 | 2.79 | 2.35 | 2.53 | 644,700 |
07/07/25 | 2.34 | 2.43 | 2.24 | 2.36 | 333,300 |
03/07/25 | 2.34 | 2.48 | 2.34 | 2.36 | 191,000 |
02/07/25 | 2.34 | 2.46 | 2.31 | 2.38 | 285,800 |
01/07/25 | 2.19 | 2.37 | 2.10 | 2.33 | 358,300 |
30/06/25 | 2.07 | 2.22 | 2.06 | 2.17 | 284,400 |
27/06/25 | 2.21 | 2.21 | 2.05 | 2.05 | 440,400 |
|
|
||||
|
|
||||
|
|